J. Biol. Chem., Vol. 275, Issue 20, 15174-15181, May 19, 2000
J Biol Chem, Vol. 275, Issue 20, 15174-15181, May 19, 2000
Reconstitution of Membranes Simulating "Glycosignaling
Domain" and Their Susceptibility to Lyso-GM3*
Kazuhisa
Iwabuchi
§
,
Yongmin
Zhang**,
Kazuko
Handa
,
Donald A.
Withers
,
Pierre
Sina
**, and
Sen-itiroh
Hakomori
§¶
From the
Pacific Northwest Research Institute,
Seattle, Washington 98122-4327, Departments of
§ Pathobiology and ¶ Microbiology, University of
Washington, Seattle, Washington 98195, and ** Ecole Normale
Supérieure, Département de Chimie, CNRS UMR 8642, 75231 Paris Cedex 05, France
 |
ABSTRACT |
GM3 ganglioside at the surface of mouse melanoma
B16 cells is clustered and organized with signal transducer molecules
c-Src, Rho A, and focal adhesion kinase (FAK) to form a membrane unit separable from caveolae, which are enriched in cholesterol and caveolin
but do not contain GM3 or the above three signal transducers. The
GM3-enriched membrane units are involved in GM3-dependent cell adhesion coupled with activation of c-Src, Rho A, and FAK and are
termed the "glycosphingolipid signaling domain" or the "glycosignaling domain" (GSD). In order to assess the essential components that display GSD function, membranes with properties similar
to those of GSD were reconstituted using GM3, sphingomyelin, and c-Src,
with or without other lipid components. The reconstituted membrane thus
prepared displayed GM3-dependent adhesion to plates coated
with Gg3 or anti-GM3 antibody, resulting in enhanced c-Src phosphorylation (c-Src phosphorylation response). This response in
reconstituted membrane depends on GM3 concentration and was not
observed when GM3 was absent or replaced with other gangliosides GM1 or
GD1a, or with LacCer. The GM3-dependent c-Src
phosphorylation response was enhanced when cholesterol and
phosphatidylcholine were added. Although GM3, sphingomyelin, and c-Src
are essential for GSD function, a small quantity of cholesterol and
phosphatidylcholine may act as an auxiliary factor to stabilize
membrane. GSD function in terms of GM3-dependent adhesion
and signaling was blocked in the presence of lyso-GM3 or its analogue
but not psychosine, lactosyl-sphingosine, or lyso-phosphatidylcholine.
Such susceptibility of reconstituted GSD to lyso-GM3 and other lyso
compounds is the same as GSD of original B16 cells. Thus, functional
organization of the reconstituted membrane closely simulates that of
GSD in B16 cells, which is based on clustered GM3 organized with c-Src
as the essential components.
 |
INTRODUCTION |
GM3 ganglioside in mouse melanoma B16 cells is clustered and
organized with c-Src, Rho A, and focal adhesion kinase
(FAK)1 and causes
GM3-dependent cell adhesion coupled with activation of
these signal transducers (1-3), leading to enhanced cell motility and
invasiveness (4, 5). The term "glycosphingolipid signaling domain"
or "glycosignaling domain" (GSD) has been assigned to such
structural and functional membrane unit (3, 6). GSD appears to be a
basic membrane unit found in various types of cells closely associated
with GSL function in terms of antigenicity and cell
adhesion/recognition coupled with signal transduction (7-9). However,
such units may have been overlooked among (or mixed up with) other
membrane units having similar properties such as cholesterol-rich,
caveolin-containing units (caveolae) involved in endocytosis and signal
transduction (10), sphingomyelin (SM)/cholesterol-rich microdomains
termed "rafts" (11), or those containing
glycosylphosphatidylinositol (GPI) anchors bearing a number of
functionally well-defined receptors (12; for review see Ref. 13).
GSD of B16 cells is enriched in GM3 and SM but has a surprisingly low
quantity of cholesterol and phospholipid, whereas caveolae have a large
quantity of cholesterol and surprisingly a very small quantity of SM.
c-Src, Rho A, and FAK but not caveolin are associated with GSD, whereas
Ras and caveolin but not other signal transducers are associated with
caveolae (3). To assess the minimal essential components showing GSD
function, membranes simulating the properties of GSD were successfully
reconstituted by a specific procedure as described in this paper, based
on the concept of reconstitution of membrane-simulating organelle
function (14). In addition, effects of various synthetic
glycosylsphingosine derivatives on GSD function in B16 cells and in
reconstituted membranes are compared. Results indicate that
sialyl-glycosylsphingosines but not lactosyl-Sph, galactosyl-Sph, or
lyso-PC, are capable of disrupting GSD structure and function in B16
cells and reconstituted membranes.
 |
MATERIALS AND METHODS |
GSLs, Lyso-GSLs, Lyso-phospholipids, Antibodies, and Other
Reagents
An outline of the synthetic scheme for
N-acetylneuraminyl
2
3Gal
1
4Glc
1
1Sph
(lyso-GM3) and
N-dichloroacetylneuraminyl
2
3Gal
1
4Glc
1
1Sph (NeuNdcAc lyso-GM3) is shown in Fig. 1.
Details of their synthesis will be described
elsewhere.2
Sialyl
2
1Sph (SA-Sph), lactosyl
1
1Sph (Lac-Sph) and
lactosyl
1
1(lactosyl
1
2)Sph(diLac-Sph) were chemically
synthesized as described
elsewhere.3

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Outline for synthesis of lyso-GM3 (7) and
NeuNdcAc lyso-GM3 (8). OSE, 2-(trimethylsilyl)ethyloxy; DBU,
1,8-diazabicyclo- [5,4,0]undec-7-ene; tBDPS,
tert-butyldiphenylsilyl; TBAF, tetrabutylammonium
fluoride.
|
|
GM3 ganglioside from dog erythrocytes (15), Gg3 (asialo-GM2) from
guinea pig erythrocytes (16), LacCer and GlcCer from bovine
erythrocytes, and anti-GM3 mAb DH2 (17) were prepared in this
laboratory. SM, phosphatidylcholine (PC), oleoyl
lyso-phosphatidylcholine (oleoyl lyso-PC), palmitoyl
lyso-phosphatidylcholine (palmitoyl lyso-PC), cholesterol, filipin, and
nystatin were purchased from Sigma. Psychosine was prepared from GalCer
by alkaline degradation in butanol (18).
Preparation of c-Src
Mouse c-Src cDNA in pUSE amp was purchased from Upstate
Biotechnology (Lake Placid, NY), excised by NotI + HindIII, cloned into a pFastBac HTa
NotI-HindIII site, and propagated in insect SF9
cells (ATCC, Rockville, MD) using a baculovirus system (Bac-to-Bac; Life Technologies, Inc.). Infected cells were grown for 4 days, harvested, and washed with phosphate-buffered saline (PBS). Cells were
resuspended (107 cells/ml) in PBS containing 1 mM
diisopropyl fluorophosphate, 10 µg/ml chymostatin, 10 µg/ml
leupeptin, and 100 µg/ml aprotinin. Sonication was performed on ice
in a sonifier (Sonifier 450; Branson Equipment Co., Shelton, CT) 30 times with 0.5-s intermittent pulses (50% "Duty Cycle" at output
2.5). The sonicate was centrifuged at 1000 × g for 5 min, the resulting supernatant was centrifuged at 8000 × g for 20 min, and the second supernatant was centrifuged at
100,000 × g for 60 min to obtain the membrane
fraction. The membrane fraction was solubilized by sonicating again for
30 s with 0.5-s intermittent pulses as above in PBS containing 17.1 mM (~0.5%) octyl
-D-glucoside, 1 mM diisopropyl fluorophosphate, 10 µg/ml chymostatin, 10 µg/ml leupeptin, and 100 µg/ml aprotinin. The solubilized materials
were precleared with anti-mouse IgG-coated Dynabeads (M450; Dynal Inc.,
Lake Success, NY) and then incubated with Dynabeads conjugated
covalently with mouse anti-c-Src monoclonal IgG (B12, Santa Cruz
Biotechnology, Santa Cruz, CA) overnight at 4 °C. Cross-linking
between anti-mouse IgG and anti-c-Src IgG at the bead surface was
performed with dimethyl pimelimidate (Sigma). After extensive washing
with sodium phosphate buffer (pH 7.4) containing 0.5 M NaCl
and 0.5% octyl glucoside, c-Src was eluted with 0.2 M
glycine-HCl buffer (pH 3) containing 0.5% octyl glucoside, and pH was
immediately adjusted to 7.4 by addition of 1 M Tris. Buffer
composition of the c-Src solution was changed by applying it to a
NAP-10 desalting column (Amersham Pharmacia Biotech) equilibrated with
50 mM Tris-HCl (pH 7.4), 0.14 M NaCl, 1 mM EDTA, and 50 mM (~1.4%) octyl glucoside.
This buffer composition was used for reconstitution of membrane
vesicles with properties similar to those of GSD.
Reconstitution of the Membrane with Composition and
Properties Similar to Those of GSD
For membrane reconstitution, types of lipids, their proportions,
and c-Src quantity were based on those observed originally in GSD
fraction (3). Reconstitution of membranes with standard lipid
composition, and varying quantities of GM3, other gangliosides, and
c-Src, was performed according to the method used for reconstituting the PC-cholesterol membrane with transmembrane receptor (19, 20), with
some modification as described below.
Standard Composition of Lipids and c-Src in Reconstituted
Membranes--
Four different combinations of lipids in
chloroform/methanol (2:1, v/v) solution: (i) GM3 (55 µg) and SM (55 µg) (referred to as "SG"); (ii) GM3 (55 µg), SM (55 µg), and
PC (55 µg) (referred to as "SGP"); (iii) GM3 (55 µg), SM (22 µg), PC (10 µg), and cholesterol (6.4 µg) (referred to as
"SGPC"); (iv) LacCer (50 µg), SM (22 µg), PC (10 µg), and
cholesterol (6.4 µg) (referred to as "SLPC") were mixed
separately and dried under a stream of N2. Each of the four
dried residues was dissolved in 968 µl of TBS (50 mM Tris-HCl (pH 7.4), 0.14 M NaCl) containing 50 mM octyl glucoside and 1 mM EDTA to which 32 µl of solution containing 3 µg of purified c-Src (50 pmol) in
replaced TBS solution as above (using NAP-10 column; see above) was
added. Because 55 µg of GM3 is approximately 50 nmol, the molarity
ratio of c-Src to GM3 was ~1:1000. The solutions were sonicated for
30 min at room temperature, and the sonicate was dialyzed against TBS
containing 1 mM EDTA at 4 °C for 24 h (1 ml of
solution versus 1 liter, changed more than 4 times). One
milliliter of the dialyzed solution was mixed with 1 ml of 85%
sucrose/TNE solution (10 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA), overlaid with 3 ml of 30%
sucrose/TNE and subsequently 5% sucrose/TNE, and centrifuged
(275,000 × g) for 17 h at 4 °C. Low density
membrane components migrated as a light-scattering band located at the
same position ("Fr. 5") as GSD of various types of cells (1, 2, 9)
and were collected.
Varied Composition of GM3, Other Gangliosides, and c-Src in
Reconstituted Membranes--
To observe the effect of GM3
concentration on c-Src activation response of reconstituted membrane,
various quantities of GM3 (from 0.86 to 110 µg) were mixed with a
fixed quantity of PC (10 µg), cholesterol (6.4 µg), and SM (22 µg) in chloroform-methanol (2:1, v/v), dried, dissolved in TBS
containing 50 mM octyl glucoside and 1 mM EDTA
as above, and added with a constant quantity of purified c-Src (3 µg;
50 pmol). The effect of c-Src quantity on the c-Src activation response
of the reconstituted membrane was studied using a lipid mixture
containing 55 µg of GM3 and fixed PC/cholesterol/SM quantities as
described above to which different quantities of c-Src (3 µg; 50 pmol; 1.5 µg; 25 pmol; or 0.75 µg; 12.5 pmol) were added. The
effect of replacing GM3 with other gangliosides (GM1, GD1a) was studied
using a lipid mixture containing 71.8 µg of GM1 or 85.4 µg of GD1a,
fixed PC/cholesterol/SM quantities as above, and 3 µg (50 pmol) of
c-Src. Membrane reconstitution was performed from lipid/c-Src mixtures
with various compositions in 50 mM octylglucoside and 1 mM EDTA by extensive dialysis followed by sucrose density
gradient centrifugation, and the low density membrane component with
the same position as Fr. 5 was collected as described above.
Determination of Reconstituted Membrane Components
Lipid Composition of Reconstituted Membranes--
Lipids were
extracted from reconstituted membrane suspension (1 ml), separated on
density gradient centrifugation with 10 ml of methanol and 20 ml of
chloroform, sonicated for 15 min, and then centrifuged. The supernatant
lipid extract was removed, and the precipitate was extracted again with
10 ml of chloroform/methanol (2:1). The first and second extracts were
combined and evaporated, and the residue was dissolved in
methanol/water (3:7, v/v), applied to a Bond Elut-packed C18 column
(Analytichem International, Harbor City, CA), and washed with the same
solvent. Finally, lipids were eluted with chloroform/methanol (2:1).
Aliquots of total lipid from reconstituted membrane (10-20% of total)
were separated by thin layer chromatography (either one- or
two-dimensional). The quantity of lipids and their ratio were
determined by densitometry in comparison with a known quantity of
standard lipid using the Scion Image program (Scion Corporation,
Frederick, MD) as described previously (3, 9). Lipid components of
reconstituted membrane were compared with those from total
detergent-insoluble membranes (DIM) and from the GSD fraction separated
by anti-GM3 mAb DH2 (3).
c-Src Associated with Reconstituted Membrane--
This was
determined by (i) immunoprecipitation with anti-c-Src antibody and (ii)
co-immunoprecipitation of c-Src with anti-GM3 mAb DH2. In the procedure
for (i), low density reconstituted membrane fraction was 10× diluted
with radioimmunoprecipitation assay (RIPA) buffer (30 mM
HEPES (pH 7.4), 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% sodium dodecyl sulfate, 5 mM EDTA, 1 mM Na3VO4, 50 mM NaF, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10% Pepstatin A,
10 µg/ml leupeptin, 10 µg/ml aprotinin), sonicated 10 min at
4 °C, precleared with Protein A-Sepharose beads, and immunoprecipitated with goat anti-c-Src antibody. RIPA buffer was used
to destroy lipid vesicles. In the procedure for (ii), the same membrane
fraction was 10× diluted with IP buffer (50 mM Tris-HCl
(pH 7.4), 150 mM NaCl, 2 mM NaF, 1 mM EDTA, 1 mM EGTA, 1 mM
Na3VO4, 1 mM PMSF, 75 units/ml
aprotinin, 0.1% Triton X-100), precleared as above,
co-immunoprecipitated with DH2, and washed with IP buffer containing
0.5 M NaCl. This procedure was necessary to maintain lipid
vesicle structure, which is resistant in this medium. The
immunoprecipitated c-Src was subjected to SDS-polyacrylamide gel
electrophoresis (PAGE) followed by Western blotting.
Determination of c-Src Phosphorylation Response to Adhesion
of Reconstituted Membrane and Effects of Lyso-sphingolipid
Derivatives
Basic Procedure for Determination of c-Src Phosphorylation
Response--
The reconstituted membrane fraction, purified by sucrose
density gradient centrifugation, corresponding to Fr. 5 was 10×
diluted with kinase buffer (30 mM HEPES (pH
7.5), 10 mM MgCl2, 2 mM
MnCl2, 1 mM CaCl2). The c-Src
phosphorylation response of membranes, adhered to 10-cm dishes coated
with Gg3 or anti-GM3 antibody, was determined as described previously
(3). Briefly, 5-ml aliquots of the diluted solution as above were added
to coated dishes, followed by centrifugation at 1500 × g (3000 rpm) at 4 °C for 30 min to ensure partial
adhesion of membrane to dishes. The dishes were kept on ice for 15 h with gentle rocking (10 strokes per minute). Separate aliquots of
diluted Fr. 5 were also mixed with lyso-GM3, its analogues, or other
glycosyl-Sph (Me2SO as vehicle; final concentration 0.5%).
Reconstituted membranes with these reagents, incubated for 30 min at
37 °C, were centrifuged and treated in the same way as above.
The c-Src activity of the reconstituted membrane and its response to
GM3-dependent membrane adhesion to the Gg3-coated dish were
determined as described previously for c-Src activity of "DIM
membrane fraction" (3) with slight modification, and activity response was compared with that of reconstituted membrane with or
without preincubation in Dulbecco's modified Eagle's medium (DMEM)
containing lyso-GM3 or other lyso-compounds, using Me2SO as
vehicle. Briefly, reconstituted membrane fraction (~5 ml) with or
without adhesion to the Gg3-coated dish was added with 2-µl aliquots
of 20 µCi of [
-32P]ATP (corresponding to 370 GBq/mmol, NEN Life Science Products) and 5 µl of 1% digitonin in
Me2SO in order to achieve final digitonin concentration of
0.001%. This digitonin concentration makes membrane vesicles permeable
but does not destroy membrane structure. The mixture was then incubated
at 37 °C for 5 min, and the reaction was stopped by placing on ice
and by addition of 5 ml of stop buffer (15 mM HEPES (pH
7.5), 150 mM NaCl, 5 mM EDTA, 1 mM
Na3VO4, 1% Triton X-100, 1 mM PMSF).
The soluble fraction was transferred to a centrifuge tube (part 1), and
the adhered membrane was desorbed and solubilized in RIPA buffer (part
2). Parts 1 and 2 were combined in the test tube (these were termed
"solubilized reconstituted membrane" fractions). The c-Src fraction
was separated preliminarily by 10% trichloroacetic acid and further
immunoprecipitated in RIPA buffer, followed by SDS-PAGE with
autoradiography as described previously (3).
Alternative Method for Comparative c-Src Response in
Reconstituted Membrane with Varying Content of GM3, Other Gangliosides,
and c-Src--
The c-Src phosphorylation response of reconstituted
membranes having various quantities of GM3 and c-Src was determined by membrane adhesion to Gg3-coated dish. Each response was simultaneously quantified by 32P radioactivity present in
immunoprecipitate with anti-c-Src antibody, without separation of c-Src
by SDS-PAGE.
The solubilized reconstituted membrane fractions prepared from
32P-labeled c-Src in the phosphorylation reaction mixture
in each dish were precipitated with trichloroacetic acid at a final
concentration of 10%. The precipitates were centrifuged, washed twice
with acetone to eliminate trichloroacetic acid, dissolved in 1.0 ml of
RIPA buffer, pH checked and adjusted to 7.4, mixed with 20 µl of
protein G-Sepharose, and placed in a rotary mixer at 4 °C for 2 h. After centrifugation at 270 × g for 5 min, the
supernatants were collected and added with anti-c-Src goat IgG at a
final IgG concentration of 1 µg/ml, incubated at 4 °C overnight,
added with 20 µl of protein G-Sepharose, and incubated at 4 °C for
2 h. Next, Sepharose beads were washed five times with RIPA
buffer, and the remaining radioactive counts were measured using a
scintillation counter (Beckman LS6500 Scintillation System, Fullerton, CA).
Imaging of GM3 Expression in Mouse Melanoma B16/F10 Cells
B16/F10 cells were obtained from Dr. I. J. Fidler, M.D.
Anderson Cancer Center, University of Texas, Houston, TX and cultured in DMEM supplemented with 10% fetal calf serum. GM3 clusters and intensity expressed at the melanoma B16 cell surface were observed by
immunofluorescence with anti-GM3 mAb DH2 as described previously (17),
and the pattern was digitally imaged using a DeltaVision microscope
(Applied Precision, Inc.) or Leica TCS-SP confocal laser scanning
microscope in the Image Analysis Lab at the Fred Hutchinson Cancer
Research Center. The degree of immunofluorescence intensity was also
determined by flow cytometry using mAb DH2.
Effects of lyso-GSL compounds on GM3 imaging were determined as
follows. Detached cells were washed 2× with DMEM, and 2.5 × 106 cells per ml of DMEM were mixed with DMEM solution
containing lyso-GM3, Lac-Sph, diLac-Sph, SA-Sph, or lyso-PC (each at 5 µM concentration), or 50 µM NeuNdcAc
lyso-GM3 (Me2SO as vehicle; final concentration 0.5%).
After 30-min incubation, cells were washed 1× with DMEM and subjected
to immunofluorescence followed by microscopy or flow cytometry as
described above.
Change of FAK in B16 Cells and of c-Src in Reconstituted
Membranes Associated with GM3-dependent Adhesion
The GM3-dependent adhesion of B16 cells to
Gg3-coated dishes and the associated change of FAK were determined as
described previously (2). The enhanced c-Src activity of the DIM
membrane fraction in response to GM3-dependent adhesion of
membrane to the Gg3-coated dish was determined as described previously
(3). The effects of preincubation with Lac-Sph and lyso-GM3 on FAK response of the B16 cells associated with GM3-dependent
cell adhesion were determined (see the legend of Fig. 7A) as
well as the c-Src phosphorylation response associated with
GM3-dependent adhesion of DIM membrane (see the legends of
Figs. 7 and 8).
 |
RESULTS |
Reconstituted Membranes Simulating the Glycosignaling Domain
(GSD)--
Although the lipid composition and associated signal
transducer molecules in GSD of mouse melanoma B16 cells are well
documented and distinct from those of caveolin-containing fraction
(caveolae) (3), the components essential for GSD function are not
clearly identified. To better identify these components, a mixture of membrane lipids and c-Src was processed to obtain reconstituted membranes showing GM3-dependent cell adhesion and
associated activation of c-Src, by the procedure described under
"Materials and Methods."
Lipid composition of reconstituted membranes, separated as low-density
fraction, is shown in Fig. 2A,
in comparison with the composition of the DIM fraction and the GSD
membrane separated by the anti-GM3 antibody (DH2) from 2 × 108 melanoma B16 cells. The lipid composition of
reconstituted membranes shown in Fig. 2A was based on 55 µg GM3, 22 µg SM, 10 µg PC, 6.4 µg cholesterol, and 3 µg
c-Src. The quantity of GM3 and SM recovered in reconstituted membrane,
separated by sucrose density gradient centrifugation, was ~22% and
~43%, respectively, of the original GM3 and SM used for membrane
reconstitution. It is noteworthy that the proportions of GM3, SM, and
PC in the reconstituted membrane fraction were very similar to those of
the GSD fraction separated by anti-GM3, but distinctively different
from those in total DIM (Fr. 5) prepared from B16 cells.
Phosphatidylserine and phosphatidylethanolamine were present in the DIM
fraction but absent in the reconstituted membrane because we did not
include these phospholipids. c-Src was clearly present in reconstituted
membrane and was co-immunoprecipitated with GM3 (Fig. 2B).
This finding indicates a close association of these components in
the reconstituted membrane, similar to GSD.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 2.
Composition of reconstituted membranes.
A, lipid composition of reconstituted membranes as compared
with the low density, detergent-insoluble membrane (DIM) and
glycosignaling domain (GSD) immunoseparated from DIM.
Left group, lipid composition of DIM isolated from 2 × 107 B16 cells as Fr. 5. Middle group,
composition of GM3- and c-Src-containing fraction (corresponding to
GSD) immunoseparated from DIM (from 2 × 108 B16
cells) by anti-GM3 mAb DH2. Right group, composition of
reconstituted membrane vesicles prepared from a mixture of
SM/GM3/PC/cholesterol/c-Src (22, 55, 10, 6.4, and 3 µg, respectively)
and separated as Fr. 5 by sucrose density gradient centrifugation.
Total lipids of reconstituted membrane were extracted, and composition
was determined using aliquots of 10-20% total lipids as described in
text. Note that the ratio of SM:GM3:PC in the resulting reconstituted
membrane is similar to that in GSD separated from total DIM, although
the lipid composition of total DIM is very different. PE,
phosphatidylethanolamine; Chl, cholesterol. Values shown are
the means of two independent experiments, with standard variation
indicated. B, c-Src present in reconstituted membranes.
Aliquots of reconstituted membranes purified by sucrose density
gradient centrifugation were (i) 10× diluted with RIPA buffer,
immunoprecipitated with goat anti-c-Src antibodies after preclearance,
and Western blotted (lane 1); (ii) 10× diluted with IP
buffer containing 0.1% Triton X-100, immunoprecipitated with anti-GM3
mAb DH2, washed with IP buffer containing 0.5 M NaCl, and
Western blotted (lane 2); (iii) same as ii, but using normal
mouse IgG instead of DH2, and Western blotted (lane 3). All
three lanes were Western blotted with rabbit anti-c-Src antibodies. For
the rationale for differential use of RIPA and IP buffer, see
"Materials and Methods, c-Src Associated with Reconstituted
Membrane." Results shown are from one typical experiment.
|
|
c-Src Phosphorylation Response of Reconstituted Membrane Coupled
with GM3-dependent Adhesion--
The c-Src phosphorylation
response was observed in three types of reconstituted membrane
containing GM3 adhered to the Gg3-coated dish, i.e. membrane
consisting of GM3/SM/c-Src (Fig. 3A, lane 3), GM3/SM/PC/c-Src (lane
5), or GM3/SM/PC/cholesterol/c-Src (lane 7). c-Src
phosphorylation was not observed in membrane without GM3,
i.e. LacCer/SM/PC/cholesterol/c-Src (lane 9). In
all cases, c-Src phosphorylation was not (or minimally) observed when
the membrane was added on the GlcCer-coated dish (Fig. 3A,
lanes 2, 4, 6, 8), or
placed in nonadherent polypropylene tube (lane 1).

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 3.
c-Src phosphorylation response of
reconstituted membranes with four different lipid compositions when
placed on dishes coated with GlcCer, Gg3, or anti-GM3 mAb.
Membranes with different lipid components and proportions were
reconstituted with c-Src as described in the text and purified by
sucrose density gradient centrifugation. A, c-Src
phosphorylation response to adhesion of these reconstituted membranes
to the Gg3-coated dish as compared with placement on the GlcCer-coated
dish. Reconstituted membranes with four different lipid compositions
(as described under "Materials and Methods") are abbreviated as
follows. SG: SM + GM3; SGP: SM + GM3 + PC; SGPC: SM + GM3 + PC + cholesterol; SLPC: SM + LacCer + PC + cholesterol. Control value is the
SGPC membrane placed in a nonadherent polypropylene tube. Results shown
are from one of two experiments with similar results. B,
c-Src phosphorylation response quantitated as fold increase of
phosphorylation relative to control (defined as 1); mean ± SD
from two independent experiments. C, c-Src phosphorylation
response to adhesion of reconstituted SGPC membrane to dishes coated
with anti-GM3 mAb DH2 (lane 3) or normal mouse IgG
(lane 2). The response of the SLPC membrane is used for
comparison (lanes 4 and 5). Control lane is the
same as that in A.
|
|
The degree of c-Src phosphorylation induced by adhesion of
reconstituted membrane to Gg3-coated versus GlcCer-coated
dishes was quantified by densitometric scanning of autoradiography
bands (Fig. 3B). The c-Src phosphorylation response occurred
only in membrane containing GM3/SM/c-Src and was higher following
addition of PC or PC/cholesterol. Optimal response was observed for the composition GM3 (55 µg), SM (22 µg), PC (10 µg), and cholesterol (6.4 µg) (referred to as "SGPC" and hereby termed "standard
composition"). There was no response for the membrane with LacCer in
place of GM3 (SLPC).
Strong c-Src phosphorylation was also observed when
GM3/SM/PC/cholesterol/c-Src-reconstituted membrane was adhered to the DH2-coated dish (Fig. 3C, lane 3). No response
was observed for membrane without GM3, i.e.
LacCer/SM/PC/cholesterol/c-Src (lane 5), or placed in a
nonadherent polypropylene tube (lane 1), or on a dish coated
with normal mouse IgG (lanes 2 and 4).
Effect of Varying Quantities of GM3 and c-Src, and Substitution of
GM3 by Other Gangliosides, on c-Src Phosphorylation Response of
Reconstituted Membrane--
The c-Src phosphorylation response of the
reconstituted membrane was optimal with the standard composition and
c-Src quantity of 3 µg (50 pmol) as described above. The response
decreased significantly when GM3 quantity was decreased, and decreased
slightly when GM3 quantity was doubled (from 55 to 110 µg). When the
c-Src quantity was decreased to 1.5 µg (25 pmol) or 0.75 µg (12.5 pmol), response also decreased significantly (Fig.
4A).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 4.
c-Src phosphorylation response of
reconstituted membranes with various quantities of GM3, other
gangliosides, and c-Src. A, reconstituted membrane
vesicles prepared from a fixed quantity of SM (22 µg), PC (10 µg),
cholesterol (6.4 µg), and c-Src (3 µg; 50 pmol) and with a varying
quantity (as indicated) of GM3 (solid bar) were adhered to
dishes coated with Gg3 or GlcCer, and c-Src phosphorylation response
was determined as described in the text. Ordinate, % response relative
to response of reconstituted membranes with standard composition
(i.e. SGPC, containing 55 µg of GM3). Response of standard
reconstituted membranes with reduced c-Src quantity, 1.5 µg (25 pmol)
or 0.75 µg (12.5 pmol), is shown by striped bars. Each
bar shows the mean ± S.D. of three experiments.
B, response of membranes containing GM1 or GD1a instead of
GM3 with fixed quantity of other lipids and c-Src as above. The binding
substrate is GlcCer or Gg3, as indicated. Ordinate as the same as that
in A.
|
|
When GM3 in reconstituted membrane (with a fixed quantity of other
lipids and c-Src) was replaced with GM1 or GD1a and the membrane was
placed on the Gg3-coated dish, c-Src phosphorylation response was very
low (Fig. 4B). This is consistent with the previous observation that only GM3, not GM1, interacts with Gg3 (4).
Effects of Lyso-GM3 and Its Analogues on GM3 Expression Pattern and
on GM3-dependent B16 Cell Adhesion--
In a search for
specific compounds that disrupt GSL clusters, which play a central role
in maintenance of structure and function of GSD, lyso-GSLs and their
derivatives were considered to interrupt cis-interaction
between GSLs (see "Discussion"). The effects of various
lyso-compounds (lyso-GM3, NeuNdcAc lyso-GM3, SA-Sph, Lac-Sph, diLac-Sph, psychosine, lyso-PC) on GSD function, in terms of
GM3-dependent B16 cell adhesion associated with FAK
enhancement and c-Src phosphorylation response, were studied initially.
Preincubation of B16 cells with 0.5-10 µM synthetic
lyso-GM3 followed by washing with DMEM strongly inhibited the
subsequent adhesion of cells to the Gg3-coated dish. Similarly,
preincubation of cells with NeuNdcAc lyso-GM3 inhibited this adhesion
at much higher concentrations (5-50 µM). In contrast,
psychosine, lyso-PC, Lac-Sph, and diLac-Sph had no inhibitory effect
even at 10 µM (Fig.
5A). Filipin at 0.07-0.47
µM and nystatin at 16-54 µM, which at
these concentrations destroy caveolae function, did not inhibit this
GM3-dependent cell adhesion (Fig. 5A). Based on
the reduced viability of cells determined by Trypan Blue exclusion
test, lyso-GM3 had no cytotoxic effect up to 10 µM but
became cytotoxic at >20 µM. NeuNdcAc lyso-GM3 had no
cytotoxic effect even at 100 µM (Fig. 5B).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of lyso-GM3, other lyso-GSLs, and
lyso-PC on GM3-dependent adhesion and viability of melanoma
B16 cells. A, effect on B16 cell adhesion to Gg3-coated
dishes. B16/F10 cells detached by EDTA/trypsin were preincubated for 30 min with various concentrations (0.05-50 µM) of GM3
( ), lyso-GM3 ( ), NeuNdcAc lyso-GM3 (small ), dilactosyl-Sph
( ), lyso-PC ( ), psychosine ( ), filipin (large ), or
nystatin ( ) in DMEM using Me2SO as vehicle (final
concentration of Me2SO in DMEM, 0.5%), followed by washing
with Me2SO and plating on Gg3- or GlcCer-coated 24-well
dishes for adhesion assay. Solid bar at left, Gg3-coated
dish as positive control. Open bar, GlcCer-coated dish as
negative control. Adhesion was expressed as percentage of total cells
added on dish. B, effect on viability of cells determined
using the Trypan Blue exclusion test. Cells were treated with various
lyso compounds as in A and subjected to a viability test.
These cells were the same samples treated with lyso compounds and used
for adhesion assay. Symbols for reagents are the same as those in
A. Assays for cell adhesion and for viability are described
in Ref. 3. For both A and B, values for lyso-GM3
and NeuNdcAc lyso-GM3 are means from three independent experiments,
values for other compounds are means from two independent experiments,
and standard variation is <10%.
|
|
The inhibitory effect of 1-5 µM lyso-GM3 or 50 µM NeuNdcAc lyso-GM3 on GM3-dependent B16
cell adhesion is ascribable to reduced anti-GM3 mAb binding, as was
observed clearly by confocal microscopy (Fig.
6A) and by fluorescent
microscopy with digital imaging (data not shown). The expression
pattern was not changed when cells were pretreated with 1-20
µM lactosyl-Sph or 1-10 µM lyso-PC. Pretreatment of cells with 50 µM NeuNdcAc lyso-GM3
clearly reduced GM3 expression observed by flow cytometry (Fig.
6B), and anti-GM3 mAb DH2 did not cross-react with this
compound (Fig. 6C). The great reduction of GM3 expression by
pretreatment of cells with even higher concentrations of lyso-GM3
(5-10 µM) was not due to release of GM3 from the cell
surface, because this treatment did not change the cell GM3 content
(Fig. 6D).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 6.
Imaging of GM3 distribution in melanoma B16
cells treated with various lyso-GSLs. A, fluorescent
images of GM3 distribution pattern by confocal microscopy. Control:
cells in DMEM containing 0.5% Me2SO. Others: cells treated
with DMEM containing various reagents, with Me2SO as
vehicle (final concentration, 0.5%). Lac-Sph, 5 µM;
Lyso-PC, 5 µM; Lyso-GM3, 5 µM; SASph, 5 µM; NeuNdcAc lyso-GM3, 50 µM. Cells were
incubated for 30 min, washed, then immunostained with anti-GM3 mAb DH2.
After incubation with a second antibody, cells were washed 3× with
PBS, fixed with 1% paraformaldehyde (4 °C, 30 min), washed 1× with
PBS, placed on a chamber slide (Nunc Inc., Naperville, IL), affixed by
centrifugation (900 rpm, 3 min), mounted with Fluorogard reagent
(Bio-Rad), and subjected to confocal microscopy. B, flow
cytometry of B16 cells treated with 50 µM NeuNdcAc
lyso-GM3 (peak 2) as compared with untreated cells
(peak 3) and control cells without antibody (peak
1). Cells treated in the same way as for the adhesion assay were
washed 3× with PBS, incubated with PBS containing mAb DH2 (1 µg/ml)
at 4 °C for 1 h, washed 2× with PBS, incubated with PBS
containing fluorescein isothiocyanate goat anti-mouse IgG at 4 °C
for 1 h, and subjected to flow cytometry. C, reactivity
of anti-GM3 mAb DH2 with GM3 (spot 1), lyso-GM3 (spot
2), NeuNdcAc lyso-GM3 (spot 3), Lac-Sph (spot
4), and diLac-Sph (spot 5). Dot blot analysis was
performed using a "Bio-dot" apparatus (Bio-Rad) as described
previously (3). D, B16 cells (2.5 × 106)
were incubated in 1 ml of DMEM containing 0.5% Me2SO
without (as control) or with 10 µM lyso-GM3 (final
concentration) for 30 min at 37 °C. Cells were centrifuged, and the
cell pellet (of the same protein quantity) was extracted using
chloroform/methanol (2:1). The total GSL fraction was developed on thin
layer chromatography with orcinol-sulfuric acid spray. Note that both
control and lyso-GM3-treated cells show the same GM3 duplet. Other
bands are not identified.
|
|
Effects of Lyso-GM3 and Its Analogues on Cellular FAK Activity and
on Membrane c-Src Activity Associated with GM3-dependent
Adhesion--
An increase of FAK activity associated with the
GM3-dependent adhesion of B16 cells to the Gg3-coated dish
was observed as described previously (2). This effect was blocked by
preincubation of B16 cells with 1-5 µM lyso-GM3 or
25-50 µM NeuNdcAc lyso-GM3 followed by washing and
adhesion but not by preincubation with 10 µM
lactosyl-Sph (Fig.
7A).

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of lyso-GM3, its derivative, and
Lac-Sph on enhanced cellular FAK activity or c-Src
phosphorylation response in membrane GSD associated with
GM3-dependent adhesion. A, effect of
various lyso compounds on enhanced FAK activity associated with
melanoma B16 cell adhesion. Cellular FAK activity was determined based
on Western blotting with anti-tyrosine phosphate antibody of
immunoprecipitated FAK (top gel, labeled
anti-pY), as compared with FAK level indicated by blotting
of the same sample with anti-FAK antibody (lower gel,
anti-FAK), as described previously (2). Cells were
preincubated in DMEM (with Me2SO as vehicle; final
concentration, 0.5%) containing lyso-GM3 (1 or 5 µM;
lanes 3 and 4), NeuNdcAc lyso-GM3 (1, 10, 25, 50 µM; lanes 5-8), or Lac-Sph (10 µM; lane 10) for 30 min, washed with DMEM,
added to Gg3-coated dishes, and adhered by centrifugation. Cells placed
in polypropylene tubes (no adhesion; resting cells, lane 1);
cells added to GlcCer-coated dishes (negative control, lane
2); or cells added to Gg3-coated dish without preincubation in any
reagent (positive control, lane 9). B, effect of
various lyso compounds on enhanced c-Src activity in membrane,
associated with adhesion of membrane to the Gg3-coated dish. DIM
containing GSD, preincubated in DMEM without reagent but containing
0.5% Me2SO, were added on the GlcCer-coated dish (negative
control; lane 1), or DIM adhered to the Gg3-coated dish
(positive control, lane 2). The same membranes were
preincubated with Lac-Sph (10 µM; lane 3),
lyso-GM3 (1, 5, or 10 µM; lanes 4-6), or
NeuNdcAc lyso-GM3 (10 or 50 µM; lanes 7 and
8), and c-Src activity was determined as explained in the
text and as described previously (3). Results shown in A and
B are each typical examples, from one out of two independent
experiments.
|
|
The great enhancement of c-Src activity in low density membrane
fraction (DIM fraction 5) upon adhesion of the membrane to the
Gg3-coated dish was inhibited by 1-10 µM lyso-GM3 or 50 µM NeuNdcAc lyso-GM3 but was unaffected by 10 µM lactosyl-Sph (Fig. 7B).
Susceptibility of Reconstituted Membrane to Lyso-GM3 Is Similar to
That of GSD of B16 Cells--
Analogous to GSD of native B16 cells
(see above), c-Src phosphorylation response in the reconstituted
membrane was strongly blocked in the presence of 1 or 5 µM lyso-GM3 (Fig. 8, lanes 6 and
7), 50 µM
NeuNdcAc lyso-GM3 (lane 5), or 1 or 5 µM
SA-Sph but was maintained when the membrane was incubated with GM3 or Lac-Sph (lanes 3 and 4) or psychosine (lane
8).

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of lyso-GSLs on
Gg3-dependent c-Src stimulation of reconstituted
membranes. Enhancement of c-Src activity in response to adhesion
to the Gg3-coated dish was determined using a reconstituted SGPC
membrane (see Fig. 3). The effect on this process by various lyso-GSLs
known to affect structure and function of GSD was tested as described
in the text. Lane 1, membrane added to the GlcCer-coated
dish. Lanes 2-9, membrane adhered to Gg3-coated dishes in
the presence of various GSLs and lyso-GSLs (Me2SO as
vehicle; final concentration, 0.5%) as described in the text.
Lane 2, control phosphorylation with the Gg3-coated dish;
lane 3, 10 µM GM3; lane 4, 10 µM Lac-Sph; lane 5, 50 µM
N-dichloroacetyl neuraminyl lyso-GM3; lane 6, 1 µM lyso-GM3; lane 7, 5 µM
lyso-GM3; lane 8, 5 µM psychosine; lane
9, 5 µM N-acetyl neuraminyl2 1Sph.
Lower panel, representative c-Src phosphorylation pattern in
gel. Upper panel, fold increase in phosphorylation measured
from gel patterns, as mean ± SD from two independent
experiments.
|
|
These results indicate that the reconstituted membrane containing GM3,
SM, and c-Src as basic components was capable of c-Src activation
response to GM3-dependent adhesion and the response was
disrupted by lyso-GM3 and its analogue, similarly to naturally occurring GSD in melanoma B16 cells.
 |
DISCUSSION |
Cellular polarity based on uneven distribution of membrane
sphingolipids, e.g. in apical and basolateral epithelial
membranes (21), gave rise to the concept that membranes consist of
different subdomains. Topological characteristics of glycosphingolipids (GSLs) are indicated by large-scale clustering of GSLs at the cell
surface (22) and the insolubility of GSLs in buffer solution containing
neutral or zwitterionic detergent (12, 23). A number of subsequent
studies indicates that sphingolipids and cholesterol are associated
with GPI anchors and Src family kinases to form structural and
functional domains (for reviews see Refs. 11 and 13), similar to
membranes derived from caveolae, which are involved in endocytosis and
signal transduction (for review see Ref. 10). However, little attention
has been paid to the functional notion of GSLs in either
sphingolipid/cholesterol domains or caveolae.
Our previous studies provide evidence that clustered GM3 or other GSLs,
organized with c-Src, Rho A, and FAK at the surface of mouse melanoma
B16 cells, form structural and functional units involved in
GM3-dependent cell adhesion as well as signal transduction (1, 2) to promote cell motility (5). Such structural units coexist in
detergent-insoluble, low density membrane fraction (DIM) with, but can
also be immunoseparated from, cholesterol-enriched, caveolin-containing
membrane units originating from caveolae (3). Similar GSL
signaling/adhesion domains have been observed in the human embryonal
carcinoma 2102 (7, 8), mouse neuroblastoma Neuro2a (9), and rat
cerebellar cells (24) and are proposed to be termed "glycosignaling
domain" (GSD) (3, 6).
These previous studies suggest that GM3, SM, and c-Src may be essential
components of GSD in B16 melanoma cells. The purpose of the present
study was to further assess essential lipid components and their
functional effect on c-Src activity in GSD, using two approaches: (i)
reconstitution of membranes displaying adhesive properties similar to
those of GSD, coupled with signal transduction through c-Src
activation; (ii) comparative effects of lyso-GM3 and other lyso
compounds on GSD function in B16 cells and in reconstituted membranes.
We successfully reconstituted membranes simulating GSD composition and
function based on a classic concept proposed by Racker (14), employing
a modified method used previously for reconstitution of PC/cholesterol
membrane vesicles with inserted transmembrane proteins, particularly
growth factor receptors or integrin receptors (19, 20).
Reconstituted membranes are characterized by the following properties:
(i) lipid composition (major lipids GM3 and SM; much smaller quantities
of PC and cholesterol) is very similar to that of naturally occurring
GSD membranes immunoseparated from caveolae fraction present in DIM
fraction; (ii) c-Src in the membrane is closely associated with GM3 as
shown by co-immunoprecipitation; (iii) the membranes bind to the solid
phase coated with Gg3 or anti-GM3 mAb, with consequent activation of
c-Src phosphorylation, but do not bind to the GlcCer-coated solid
phase, and hence no c-Src phosphorylation occurs; (iv) optimal adhesion
and c-Src phosphorylation response are observed with a certain
composition of GM3, c-Src, and other lipid components, but the response
is lower when the quantity of GM3 or c-Src is reduced; (v) the
reconstituted membrane in which GM3 is replaced by GM1, GD1a, or LacCer
does not show binding to Gg3 or anti-GM3 mAb, or consequent c-Src
phosphorylation response; (vi) addition of cholesterol and PC
significantly increases the c-Src phosphorylation response; and (vii)
binding to solid-phase Gg3 and c-Src phosphorylation response is
blocked by lyso-GM3 or its derivative, but the binding is not affected
by lyso-PC, psychosine, or Lac-Sph. All these properties of
reconstituted membranes are very similar to those of GSD in B16 cells
(2, 3), indicating that GM3, SM, and c-Src are essential components of
GSD, whereas PC and cholesterol are auxiliary components that enhance
or stabilize GSD function.
A major question remaining to be elucidated is the mechanism by which
c-Src incorporated in the lipid bilayer is activated when external GM3
is stimulated by its ligand. In view of recent findings on crystal
structure, c-Src activation is thought to be based on disordering of
autoinhibitory interaction between intramolecular subunits, leading to
Tyr416 autophosphorylation. This is associated with
distortion of an ordered helical loop located between the "N-lobe"
and the "C-lobe" of the kinase domain (25). Activation does not
necessarily always depend on dephosphorylation of Tyr527 at
the C terminus, which was previously considered to lock the molecule in
an inhibited conformation (26). Tyr527-independent
activation of Src kinase through sulfhydryl group modification was
proposed recently (27). c-Src produced in SF9 cells using the
baculovirus system is an inactive form that lacks Tyr416
phosphorylation. Such inactive c-Src is activated by external ligand
bound to SH3 and SH2 domains (25, 28). It is crucial to elucidate the
mechanism causing activation of c-Src, bound to the lipid bilayer, by
enhanced clustering of GM3. The mechanism may be analogous to
activation of cytoplasmic tyrosine kinase induced by growth
factor-dependent clustering of its receptor (29).
Glycosyl-Sph, having sialic acid and N-unsubstituted Sph,
was found to disrupt GSD function, as indicated by inhibition of GM3
immunostaining by anti-GM3 DH2, and inhibition of
GM3-dependent adhesion and associated FAK activity and
c-Src phosphorylation response. The simplest compound of this type is
SA-Sph, as previously found (30). In the present study, two other
compounds, lyso-GM3 and NeuNdcAc lyso-GM3, were found to also disrupt
GSD function. Other lyso-GSLs and lyso-PC had no effect at similar
concentration. The effect of glycosyl-Sph on GSD is in striking
contrast to the effect of cholesterol-binding reagents that disrupt
caveolae structure and function. Significantly, the disruptive effect
of lyso-GM3 and its analogue on GSD in reconstituted membrane is
similar to that in native B16 cells.
The effect of lyso-GM3 on GSD function may well be due to disruption of
cis interaction of GM3 and consequent dispersion of GM3
clustering, although further extensive study is needed to clarify the
exact mechanism. Preincubation of cells with 1-5 µM lyso-GM3, followed by washing, greatly reduced staining with anti-GM3 mAb DH2 and GM3 clustering, without changing the cellular level of GM3.
The reduction of DH2 staining was not due to competitive inhibition of
DH2 binding to the cell surface by lyso-GM3, because cells were washed
before the DH2 was added, lyso-GM3 cross-reacts with DH2 (Fig.
5C), and a large quantity of lyso-GM3 was inserted in the
membrane even though the GM3 content was unchanged (Fig. 5D). Lyso-GM3, therefore, may cause a change in GM3
organization (e.g. dispersion of GM3 clustering as above).
The blocking effect of lyso-GM3 and its analogue on FAK activity and
c-Src phosphorylation response must be considered a consequence of GM3
organizational change in GSD, in both B16 cells and in reconstituted membrane.
Activated c-Src often appears as a doublet band on SDS gel, analogous
to membrane-bound c-Src (31) (see legend of Fig. 3A). An
effect on GSD similar to that observed for lyso-GM3 was found previously for sialyl
2
1Sph (30). Neither filipin nor nystatin had
an effect on GM3-dependent adhesion and associated FAK
activation (3) at doses that disrupt caveolae structure and function
(32, 33). Interestingly, the reconstituted membrane showed the same susceptibility to lyso-ganglioside analogues as the original B16 cells
or isolated GSD membrane fraction.
In summary, reconstituted membranes show all the characteristic
properties of GSD from melanoma B16 cells. GSD from other cell types is
characterized by different major GSLs in combination with different
signal transducers (7-9, 24). A close association and interaction
between clustered GSLs and signal transducers, particularly Src family
kinases, small G-proteins, and FAK, play a central role in cellular
interactions coupled with signal transduction in general.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Jonathan Cooper (Fred Hutchinson
Cancer Research Center, Seattle, WA) and Dr. Wenqing Xu (Department of
Biological Structure, University of Washington, Seattle, WA) for advice
on the c-Src preparation and the possible c-Src activation mechanism and Dr. Stephen Anderson for scientific editing and preparation of the manuscript.
 |
FOOTNOTES |
*
This work was supported by National Cancer Institute Grants
OIG CA42505 and CA80054 (to S. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Department of Biochemistry-2, Juntendo
University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

To whom correspondence should be addressed. Pacific Northwest
Research Institute, 720 Broadway, Seattle, WA 98122-4327. E-mail: hakomori@u.washington.edu.
2
Zhang, Y., Hakomori, S., and Sina
, P.,
unpublished data.
3
Zhang, Y., Toyokuni, T., and Hakomori, S.,
unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
FAK, focal
adhesion kinase;
DIM, detergent-insoluble membranes separated as low
density fraction by density gradient centrifugation;
PMSF, phenylmethylsulfonyl fluoride;
DMEM, Dulbecco's modified Eagle's
medium;
GSD, glycosphingolipid signaling domain ("glycosignaling
domain") immunoseparated from DIM by anti-GSL antibodies;
Lac-Sph, lactosylsphingosine (Gal
1
4Glc
1
1sphingosine);
diLac-Sph, dilactosylsphingosine (Lac
1
1[Lac
1
2]sphingosine);
lyso-GM3, NeuAc
2
3Gal
1
4Glc
1
1sphingosine;
lyso-PC, lyso-phosphatidylcholine (1-acylglycerophosphorylcholine);
NeuNdcAc lyso-GM3, N-
dichloroacetylneuraminyl
2
3Gal
1
4Glc
1
1Sph;
PC, phosphatidylcholine;
psychosine, Gal
1
1sphingosine;
PAGE, polyacrylamide gel electrophoresis;
SM, sphingomyelin;
Sph, sphingosine;
mAb, monoclonal antibody;
RIPA, radioimmunoprecipitation
assay;
PBS, phosphate-buffered saline.
 |
REFERENCES |
| 1.
|
Yamamura, S.,
Handa, K.,
and Hakomori, S.
(1997)
Biochem. Biophys. Res. Commun.
236,
218-222[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Iwabuchi, K.,
Yamamura, S.,
Prinetti, A.,
Handa, K.,
and Hakomori, S.
(1998)
J. Biol. Chem.
273,
9130-9138[Abstract/Free Full Text]
|
| 3.
|
Iwabuchi, K.,
Handa, K.,
and Hakomori, S.
(1998)
J. Biol. Chem.
273,
33766-33773[Abstract/Free Full Text]
|
| 4.
|
Kojima, N.,
and Hakomori, S.
(1991)
J. Biol. Chem.
266,
17552-17558[Abstract/Free Full Text]
|
| 5.
|
Kojima, N.,
Shiota, M.,
Sadahira, Y.,
Handa, K.,
and Hakomori, S.
(1992)
J. Biol. Chem.
267,
17264-17270[Abstract/Free Full Text]
|
| 6.
|
Hakomori, S.,
Handa, K.,
Iwabuchi, K.,
Yamamura, S.,
and Prinetti, A.
(1998)
Glycobiology
8,
xi-xviii
|
| 7.
|
Yu, S.,
Withers, D. A.,
Yamamura, S.,
Handa, K.,
and Hakomori, S.
(1997)
Glycoconj. J.
14 (suppl.),
S53
|
| 8.
|
Yu, S.,
Withers, D. A.,
and Hakomori, S.
(1998)
J. Biol. Chem.
273,
2517-2525[Abstract/Free Full Text]
|
| 9.
|
Prinetti, A.,
Iwabuchi, K.,
and Hakomori, S.
(1999)
J. Biol. Chem.
274,
20916-20924[Abstract/Free Full Text]
|
| 10.
|
Anderson, R. G. W.
(1998)
Annu. Rev. Biochem.
67,
199-225[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Hooper, N. M.
(1998)
Curr. Biol.
8,
R114-R116[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Brown, D. A.,
and Rose, J. K.
(1992)
Cell
68,
533-544[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Brown, D. A.,
and London, E.
(1997)
Biochem. Biophys. Res. Commun.
240,
1-7[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Racker, E.
(1985)
Reconstitutions of Transporters, Receptors, and Pathological States
, Academic Press, Orlando, FL
|
| 15.
|
Klenk, E.,
and Heuer, K.
(1960)
Z. Verdauungs u Stoffwechselkrankheiten
20,
180-183
|
| 16.
|
Seyama, Y.,
and Yamakawa, T.
(1974)
J. Biochem.(Tokyo)
75,
837-842[Abstract/Free Full Text]
|
| 17.
|
Dohi, T.,
Nores, G.,
and Hakomori, S.
(1988)
Cancer Res.
48,
5680-5685[Abstract/Free Full Text]
|
| 18.
|
Taketomi, T.,
and Yamakawa, T.
(1963)
J. Biol. Chem.
54,
444-451
|
| 19.
|
Mimms, L. T.,
Zampighi, G.,
Nozaki, Y.,
Tanford, C.,
and Reynolds, J. A.
(1981)
Biochemistry
20,
833-840[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Zheng, M.,
Fang, H.,
Tsuruoka, T.,
Tsuji, T.,
Sasaki, T.,
and Hakomori, S.
(1993)
J. Biol. Chem.
268,
2217-2222[Abstract/Free Full Text]
|
| 21.
|
Simons, K.,
and van Meer, G.
(1988)
Biochemistry
27,
6197-6202[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Tillack, T. W.,
Allietta, M.,
Moran, R. E.,
and Young, W. W. J.
(1983)
Biochim. Biophys. Acta
733,
15-24[Medline]
[Order article via Infotrieve]
|
| 23.
|
Okada, Y.,
Mugnai, G.,
Bremer, E. G.,
and Hakomori, S.
(1984)
Exp. Cell Res.
155,
448-456[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Kasahara, K.,
Watanabe, Y.,
Yamamoto, T.,
and Sanai, Y.
(1997)
J. Biol. Chem.
272,
29947-29953[Abstract/Free Full Text]
|
| 25.
|
Xu, W.,
Doshi, A.,
Lei, M.,
Eck, M. J.,
and Harrison, S. C.
(1999)
Mol. Cell
3,
629-638[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Matsuda, M.,
Mayer, B. J.,
Fukui, Y.,
and Hanafusa, H.
(1990)
Science
248,
1537-1539[Abstract/Free Full Text]
|
| 27.
|
Akhand, A. A.,
Pu, M.,
Senga, T.,
Kato, M.,
Suzuki, H.,
Miyata, T.,
Hamaguchi, M.,
and Nakashima, I.
(1999)
J. Biol. Chem.
274,
25821-25826[Abstract/Free Full Text]
|
| 28.
|
Thomas, J. W.,
Ellis, B.,
Boerner, R. J.,
Knight, W. B.,
White, G. C.,
and Schaller, M. D.
(1998)
J. Biol. Chem.
273,
577-583[Abstract/Free Full Text]
|
| 29.
|
Ullrich, A.,
and Schlessinger, J.
(1990)
Cell
61,
203-212[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Zhang, Y.,
Iwabuchi, K.,
Nunomura, S.,
and Hakomori, S.
(2000)
Biochemistry
39,
2459-2468[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Courtneidge, S. A.,
Levinson, A. D.,
and Bishop, J. M.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
3783-3787[Abstract/Free Full Text]
|
| 32.
|
Schnitzer, J. E.,
Oh, P.,
Pinney, E.,
and Allard, J.
(1994)
J. Cell Biol.
127,
1217-1232[Abstract/Free Full Text]
|
| 33.
|
Baorto, D. M.,
Gao, Z.,
Malaviya, R.,
Dustin, M. L.,
van der Merwe, A.,
Lublin, D. M.,
and Abraham, S. N.
(1997)
Nature
389,
636-639[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. J. Park, M. Suh, B. Thomson, A. B.R. Thomson, K. S. Ramanujam, and M. T. |